Interrater Reliability of AMDP and AMP Symptoms

Frequency of manic symptoms during a depressive episode and unipolar ‘depressive mixed state’ as bipolar spectrum

“…Each psychiatric symptom of the AMDP system is scored from 0 (absent) to 3 (severe) with defined anchor statements by using a semistructured interview method. Several studies indicated moderate to high interrater agreements for included symptoms (29, 30). Among the psychiatric symptoms assessed, 11 manic and mania‐related symptoms were selected.…”

“…The depression severity was measured by using the AMDP depression scale (31, 32), which is calculated by summing up 13 AMDP item scores for rumination, loss of feeling, loss of vitality, depressed mood, hopelessness, feeling of inadequacy, feeling of guilt, inhibition of drive, worse in the morning, interrupted sleep, shortened sleep, early waking, and decreased appetite. This scale was previously validated in large psychiatric samples (28, 29). Alpha coefficient for this scale in our study group was 0.793, indicating substantial internal consistency.…”

Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia

“…The AMDP instrument has shown good (moderate to excellent) inter‐rater reliability as well as validity (10, 12, 13). In particular, Kuny et al.…”

“…In particular, Kuny et al. (13), in a study with psychiatric residents, found that the inter‐rater reliability for hallucinations was good to excellent (kappa‐scores ranging from 0.65 to 1) with the exception of somatic hallucinations (kappa: 0.45 = moderate reliability). Kappa‐scores for anxiety and insight were 0.52 and 0.50 respectively (moderate inter‐rater reliability).…”

The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients

“…However, although the relationship between the drug and the somatic symptoms is recorded, no definition of this relationship is given. On the other hand, the third edition of the AMDP system seems in generalconcerning the presence or absence of the somatic symptomsto have an adequate interobserver reliability (24). Studies in which the somatic part of the AMDP system has been used as a side effect rating scale are still lacking.…”